Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Perioperative factor XIII and viscoelastic measurements of open compared to minimal invasive major upper gastrointestinal surgery- A prospective observational study.

Thrombosis research·2026

Same author

Transurethral catheter in the distal ureter as a cause for acute abdominal pain.

BMJ case reports·2025

Same author

Trends in pre-hospital volume resuscitation of blunt trauma patients: a 15-year analysis of the British (TARN) and German (TraumaRegister DGU®) National Registries.

Critical care (London, England)·2024

Same author

Discrepancies between clinical diagnoses and autopsy findings: A comparative study conducted in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2022

Same author

Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.

Intensive care medicine·2020

Same author

A prospective observational study of the rapid detection of clinically-relevant plasma direct oral anticoagulant levels following acute traumatic injury.

Anaesthesia·2020

Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026

Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 28, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Trauma-associated hyperfibrinolysis.

H Schöchl¹, W Voelckel, M Maegele

¹Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria. herbert.schoechl@trauma.lbg.ac.at

Hamostaseologie

|October 20, 2011

Summary

This summary is machine-generated.

Trauma-induced coagulopathy (TIC) is complex, involving factor depletion and dysfunction. Emerging evidence highlights hyperfibrinolysis (HF) as a key factor, with early tranexamic acid treatment potentially reducing mortality in trauma patients.

More Related Videos

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Area of Science:

Traumatology
Hematology
Critical Care Medicine

Background:

Trauma-induced coagulopathy (TIC) traditionally attributed to factor depletion and dysfunction (hypothermia, acidosis).
Recent research identifies hyperfibrinolysis (HF) as a significant, often overlooked, contributor to coagulopathy in trauma.
HF is driven by severe shock and major tissue trauma, with its incidence still under investigation.

Purpose of the Study:

To explore the role of hyperfibrinolysis in trauma-induced coagulopathy.
To discuss the diagnostic challenges of occult HF.
To evaluate the potential benefit of early antifibrinolytic therapy in trauma patients.

Main Methods:

Review of existing literature on trauma-induced coagulopathy and hyperfibrinolysis.
Analysis of data from visco-elastic tests in trauma patients.
Consideration of findings from a randomized, placebo-controlled trial on tranexamic acid.

Main Results:

Visco-elastic tests suggest HF incidence of 2.5-7% in trauma patients, detecting severe forms only.
Occult HF is likely more prevalent but difficult to diagnose.
A randomized trial indicated that early tranexamic acid administration may significantly decrease trauma-associated mortality.

Conclusions:

Hyperfibrinolysis is a critical, underdiagnosed component of trauma-induced coagulopathy.
Early administration of tranexamic acid shows promise in mitigating mortality in trauma patients.
Further research is needed to improve HF diagnosis and optimize treatment strategies.